Use of sofosbuvir based regimen in patients with end-stage renal disease and chronic hepatitis C; an open label, non-randomized, single arm, single center study from Pakistan

AIM: we aimed to determine the virological response and safety of Sofosbuvir-based direct-acting antiviral agents (DAAs) in chronic hepatitis C (CHC) patients on long-term hemodialysis (HD). BACKGROUND: With the advent of interferon-free DAAs, the treatment of CHC has been revolutionized. Pakistan i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Gastroenterol Hepatol Bed Bench
Autori principali: Mandhwani, Rajesh, Hanif, Farina M., Lail, Ghulamullah, Luck, Nasir Hassan, Khalid, Muhammad Ali, ul Haque, Muhammad Manzoor, Laeeq, Syed Mudassir, Aziz, Tahir
Natura: Artigo
Lingua:Inglês
Pubblicazione: Shaheed Beheshti University of Medical Sciences 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7149816/
https://ncbi.nlm.nih.gov/pubmed/32308935
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi